5,124
Views
2
CrossRef citations to date
0
Altmetric
Review Article

Whistleblowing as an anti-corruption strategy in health and pharmaceutical organizations in low- and middle-income countries: a scoping review

ORCID Icon, ORCID Icon & ORCID Icon
Article: 2140494 | Received 05 Aug 2022, Accepted 21 Oct 2022, Published online: 10 Nov 2022

References

  • United Nations Office on Drugs and Crime. United nations convention against corruption. New York: United Nations; 2004.
  • Jones B, Jing A. Prevention not cure in tackling health-care fraud. Bull World Health Organ. 2011 Dec 1;89:858–14.
  • Vian T. Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches. Glob Health Action. 2020;13:1694744.
  • Shrank WH, Rogstad TL, Parekh N. Waste in the US health care system: estimated costs and potential for savings. JAMA. 2019 Oct 15;322:1501–1509.
  • Kohler J, Dimancesco D. The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk. Glob Health Action. 2020;13:1694745.
  • National Academies of Sciences Engineering and Medicine. The critical health impacts of corruption. In: National academies of sciences engineering and medicine, editor. Crossing the global quality chasm: Improving health care worldwide. Washington (DC): The National Academies Press; 2018. p. 203–225.
  • Uchendu FN, Abolarin TO. Corrupt practices negatively influenced food security and live expectancy in developing countries. Pan Afr Med J. 2015;20:110.
  • Achim M, Văidean V, Borlea S. Corruption and health outcomes within an economic and cultural framework. Eur J Health Econ. 2020;21:195–207.
  • Holmberg S, Rothstein B. Dying of corruption. Health Econ Policy Law. 2011;6:529–547.
  • Organization for Economic Cooperation and Development [OECD]. OECD Public Integrity Handbook. Paris: OECD Publishing; 2020.
  • UNODC. State of integrity: a guide on conducting corruption risk assessments in public organizations. Vienna: United Nations; 2020.
  • Samuels J, Pope K. Are organizations hindering employee whistleblowing?. J Accountancy. 2014 [cited 2022 Aug 5]. https://www.journalofaccountancy.com/issues/2014/dec/employee-whistleblowers-corporate-fraud.html
  • Owusu G, Bekoe R, Anokye F, Okoe F. Whistleblowing intentions of accounting students: an application of the theory of planned behavior. J Financ Crime. 2020;27:477–492.
  • Armitage R, Nellums LB. Whistleblowing and patient safety during COVID-19. EClinicalMedicine. 2020 Jul;24:100425.
  • United Nations Office on Drugs and Crime. Speak-up for health: guidelines to enable whistle-blower protection in the health-care sector. Vienna: UNODC; 2021. pp. 1–76.
  • OECD. Policy measures to avoid corruption and bribery in the COVID-19 response and recovery. Paris: OECD Publishing; 2020.
  • Pohjanoksa J, Stolt M, Suhonen R, Löyttyniemi E, Leino-Kilpi H. Whistle-blowing process in healthcare: from suspicion to action. Nurs Ethics. 2019;26:526–540.
  • Greene A, L JK. Whistle-blowing as a form of advocacy: guidelines for the practitioner and organization. Soc Work. 2004;49:219–230.
  • Corruption Watch. The whistleblower’s handbook. South Africa: Corruption Watch; 2020.
  • Blenkinsopp J, Snowden N, Mannion R, Powell M, Davies H, Millar R, et al. Whistleblowing over patient safety and care quality: a review of the literature. J Health Organ Manag. 2019;33:737–756.
  • United Nations Office on Drugs and Crime. The United Nations convention against corruption resource guide on good practices in the protection of reporting persons. United Nations. 2015;1–99. https://www.unodc.org/documents/corruption/Publications/2015/15-04741_Person_Guide_eBook.pdf
  • Moy GG. The role of whistleblowers in protecting the safety and integrity of the food supply. NPJ Sci Food. 2018;2:8.
  • Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8:19–32.
  • Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18:143.
  • Kang MM. Whistleblowing in the public sector: a systematic literature review. Rev Public Pers Adm. 2022;0734371X2210787. DOI:10.1177/0734371X221078784
  • Mugellini G, Bella SD, Colagrossi M, Isenring GL, Killias M. Public sector reforms and their impact on the level of corruption: a systematic review. Campbell Syst Rev. 2021;17:e1173.
  • Kelly D, Jones A. When care is needed: the role of whistleblowing in promoting best standards from an individual and organizational perspective. Qual Ageing. 2013;14:180–191.
  • Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18:2119–2126. DOI:10.11124/JBIES-20-00167
  • Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467–473.
  • Vian T, Agnew B, McInnes K. Whistleblowing as an anti-corruption strategy in health and pharmaceutical organizations: a scoping review protocol. Open Science Framework. 2021. DOI:https://doi.org/10.17605/OSF.IO/2W3G8
  • Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5:69.
  • World Health Organization. Everybody’s business: strengthening health systems to improve health outcomes – WHO’s framework for action. Geneva: WHO; 2007.
  • Transparency International. Whistleblower protection and the UN convention against corruption. Berlin: Transparency International; 2013.
  • Chang Z, Rusu V, Kohler JC. The global fund: why anti-corruption, transparency and accountability matter [Article]. Glob Health. 2021;17. DOI:10.1186/s12992-021-00753-w
  • European Commission. Frequently asked questions: whistleblower protection. Memo 18/3442. Brussels: European Commission; 2018. pp. 1–5.
  • Reynolds L. Not up for discussion: applying lukes’ power model to the study of health system corruption comment on “we need to talk about corruption in health systems” [Note]. Int J Health Policy Manag. 2019;8:723–726.
  • Soon J, Manning L. Whistleblowing as a countermeasure strategy against food crime. Br Food J. 2017;119:2630–2652.
  • Bagcchi S. Website to report corruption in medicine launches in India. BMJ. 2014 Dec 8;349:g7539. DOI:10.1136/bmj.g7539.
  • Gavi. Report to the board from audit and investigations, 30 November - 2 December 2021. Geneva: Gavi; 2021.
  • World Health Organization. Compliance, risk management and ethics: annual report. EBPBAC34/4. Geneva: WHO Programme, Budget, and Administration Committee of the Executive Board; 2021. pp. 1–6.
  • European Partners against Corruption (EPAC). European contact-point network against corruption (EACN). Manual on preventing corruption and promoting integrity. Austria: EPAC/EACN; 2022. pp. 1–314.
  • The Global Fund Office of the Inspector General. Whistle-blowing policy and procedures for the global fund to fight AIDS, tuberculosis and malaria. The Global Fund. 2019;1–7.
  • European Union. Directive (EU) 2019/1937 of the European parliament and of the council of 23 October 2019 on the protection of persons who report breaches of Union law. Luxembourg: European Union; 2019. pp. 1–39.
  • Gavi. Gavi alliance whistleblowing policy version 4.0. Geneva: Gavi; 2020.
  • World Health Organization. WHO whistleblowing and protection against retaliation. Policy and procedures. Geneva: WHO Office of Compliance, Risk Management, and Ethics; 2015. pp. 1–14.
  • Bhan A. Health ministry institutes reward scheme for whistle-blowers reporting spurious drugs [Note]. Natl Med J India. 2010;23:56.
  • Zouanat S. Exposing corruption in Morocco’s hospitals [Internet]. Berlin: Transparency International; 2019. Available from: https://www.transparency.org/en/blog/exposing-corruption-in-moroccos-hospitals.
  • Jayaraman K. Failure of Indian whistleblower scheme points to deeper woes. Nat Med. 2010 Apr;16:364.
  • Milata P. Fraud’s impact on healthcare during COVID-19. Global survey on fraud and corruption affecting healthcare systems during COVID-19 in April 2020. Berlin: Nemexis; 2020. pp. 1–66.
  • Chatterjee P. Whistleblowing in India: what protections can doctors who raise concerns expect? BMJ. 2015;350:350.
  • Transparency International. COVID-19 makes women more vulnerable to corruption[Internet]. Berlin: Transparency International; 2020. [cited 2022]. Available from: https://www.transparency.org/en/news/covid-19-makes-women-more-vulnerable-to-corruption
  • Transparency International. How corruption is making people sick [Internet]. Berlin: Transparency International; 2020 [cited 2022]. Available from: https://www.transparency.org/en/news/how-corruption-is-making-people-sick
  • The Global Fund Office of the Inspector General. Anti-fraud and corruption tool kit for implementers. The Global Fund. 2017. https://www.ispeakoutnow.org/resources-en/
  • Flanagan J. Covid corruption whistleblower shot dead Times; 2021 25 Aug [cited 2022 21 Sep]. Available from: link.gale.com/apps/doc/A673126852/AONE?u=usfca_gleeson&sid=bookmark-AONE&xid=86ac1a84
  • Zúñiga N. Gender sensitivity in corruption reporting and whistleblowing. U4 helpdesk answer. Norway: U4 Anti-Corruption Resource Centre. 2020;10:1–11.
  • Transparency International. Speaking up safely: civil society guide to whistleblowing middle East and North Africa region; 2015. p. 1–41.
  • Bedford O. The relation between guanxi and interpersonal trust in the workplace. Integr Psychol Behav Sci. 2022;56:385–404.
  • Hwang D, Staley B, Chen Y, Lan J-S. Confucian culture and whistle-blowing by professional accountants: an exploratory study. Manag Audit J. 2008;23:504–526.
  • Peiffer C, Armytage R, Marquette H, Gumisiriza P. Lessons from reducing bribery in Uganda’s health services. Dev Policy Rev. 2020;39:721–739.
  • Anvari F, Wenzel M, Woodyatt L, Haslam S. The social psychology of whistleblowing: an integrated model. Organ Psychol Rev. 2019;9:41–67.
  • Zakaria M, Azmawaty Abd Razak S, Yusoff M. The theory of planned behavior as a framework for whistle-blowing intentions. Rev Eur Stud. 2016;8:221–236.
  • Cho Y, Song H. Determinants of whistleblowing within government agencies. Public Pers Manage. 2015;44:450–472.
  • Tavares GM, Lima FV, Michener G. To blow the whistle in Brazil: the impact of gender and public service motivation. Regul Gov. 2021 June;2021:1–19.
  • Crown Agents. Combating heart disease and child and adult cancer: crown agents in new partnership with Ukrainian ministry of health: Crown Agents; 2019 [cited June 29, 2022]. Available from: https://www.crownagents.com/news-item/combating-heart-disease-and-child-and-adult-cancer-crown-agents-in-new-partnership-with-ukrainian-ministry-of-health
  • Cheng X, Karim K, Lin K. A cross-cultural comparison of whistleblowing perceptions. Int J Manag Decis Mak. 2015;14:15.
  • Park H, Rehg M, Lee D. The influence of confusian ethics and collectivism on whistleblowing intentions: a study of South Korean public employees. J Bus Ethics. 2005;48:387–403.